It is expected that Glaxo Wellcome and SmithKline Beecham will complete their merger on Dec.27, 2000-nearly a year after unveiling their plans to become a conglomerate.
The British drug groups are waiting for approval of the deal from the US Federal Trade Commission (FTC) before going in front of Britain's High Court next week for final clearance.
GlaxoSmithKline would become the largest pharmaceutical company worldwide by market share, controlling more than 7% of the world market. The first financial results to be reported by GlaxoSmithKline will be for the year ending Dec. 31 and will be announced in February.
The merger was expected to be complete last May; however, the FTC had questions about the companies' combined power in certain markets.
Information from The Wall Street Journal.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.